ISSN: 0169-409X
Journal Home
Journal Guideline
Advanced Drug Delivery Reviews Q1 Unclaimed
Advanced Drug Delivery Reviews is a journal indexed in SJR in Pharmaceutical Science with an H index of 366. It has an SJR impact factor of 3,411 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,411.
Advanced Drug Delivery Reviews focuses its scope in these topics and keywords: drug, delivery, challenges, therapy, controlled, mechanisms, metabolism, strategies, engineering, therapeutic, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
3,411
SJR Impact factor366
H Index198
Total Docs (Last Year)737
Total Docs (3 years)40639
Total Refs12569
Total Cites (3 years)702
Citable Docs (3 years)15.21
Cites/Doc (2 years)205.25
Ref/DocOther journals with similar parameters
Nano Today Q1
Advanced healthcare materials Q1
Journal of Controlled Release Q1
Journal of Nanobiotechnology Q1
Asian Journal of Pharmaceutical Sciences Q1
Compare this journals
Aims and Scope
Best articles by citations
Biodegradable implant strategies for inhibition of restenosis
View moreCytokines as adjuvants for the induction of mucosal immunity
View moreEndocytosis and sorting of macromolecules
View moreAlkylating agent prodrugs for ADEPT
View moreOptical nanosensors - towards the development of intracellular monitoring
View moreMicroparticle targeting to M cells
View moreGene-directed enzyme prodrug therapy (GDEPT): choice of prodrugs
View moreReceptor versus non-receptor mediated clearance of liposomes
View moreQuantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors
View morePreparation and purification of antibody-enzyme conjugates for therapeutic applications
View moreThe distribution and chemical kinetics of prostaglandin E1 in lipid emulsions
View moreApplications of genetic engineering in veterinary medicine
View moreDevelopment of adjuvant-active nonionic block copolymers
View moreEditorial
View moreChallenges in the clinical assessment of novel tuberculosis drugs
View moreUse of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
View moreFirst clinical experience with ADEPT
View moreCells for drug delivery platforms
View moreMicroencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens
View moreGraphene-based hybrid materials and devices for biosensing
View morePreface
View moreDelivery of antimicrobials to infected tissue macrophages
View moreInteraction of liposomes with human skin: the role of the stratum corneum
View moreFibroblasts and extracellular matrix: Targeting and therapeutic tools in fibrosis and cancer
View more
Comments